{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:42:43Z","timestamp":1791088963973,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1981,11,1]],"date-time":"1981-11-01T00:00:00Z","timestamp":373420800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Agents and Actions"],"published-print":{"date-parts":[[1981,11]]},"DOI":"10.1007\/bf02004716","type":"journal-article","created":{"date-parts":[[2005,8,11]],"date-time":"2005-08-11T13:25:47Z","timestamp":1123766747000},"page":"520-531","source":"Crossref","is-referenced-by-count":23,"title":["Atropine: A sensitive gas chromatography\u2014mass spectrometry assay and prepharmacokinetic studies"],"prefix":"10.1007","volume":"11","author":[{"given":"M.","family":"Eckert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. H.","family":"Hinderling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02004716_CR1","first-page":"516","volume-title":"The Pharmacological Basis of Therapeutics","author":"L.S. Goodman","year":"1977","unstructured":"L.S. Goodman andA. Gilman,The Pharmacological Basis of Therapeutics 5th edn., p. 516. The MacMillan Company, New York 1977.","edition":"5th edn."},{"key":"BF02004716_CR2","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1600-0773.1950.tb03461.x","volume":"6","author":"M. T\u00f8nnesen","year":"1950","unstructured":"M. T\u00f8nnesen,The excretion of atropine and allied alkaloids in urine, Acta Pharmac.6, 147\u2013164 (1950).","journal-title":"Acta Pharmac."},{"key":"BF02004716_CR3","first-page":"597","volume":"1","author":"R.E. Gosselin","year":"1960","unstructured":"R.E. Gosselin, J.D. Gabourel andJ.H. Wills,The fate of atropine in man, Clin. Pharmac. Ther.1, 597\u2013603 (1960).","journal-title":"Clin. Pharmac. Ther."},{"key":"BF02004716_CR4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1749-6632.1971.tb46943.x","volume":"179","author":"S.C. Kalser","year":"1971","unstructured":"S.C. Kalser The fate of atropine in man, Ann. N.Y. Acad. Sci.179, 667\u2013683 (1971).","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"BF02004716_CR5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/cpt1970112214","volume":"11","author":"S.C. Kalser","year":"1970","unstructured":"S.C. Kalser,andP.L. McLain,Atropine metabolism in man, Clin. Pharmac. Ther.11, 214\u2013227 (1970).","journal-title":"Clin. Pharmac. Ther."},{"key":"BF02004716_CR6","first-page":"435","volume":"203","author":"R.J. Wurzburger","year":"1977","unstructured":"R.J. Wurzburger, R.L. Miller, H.G. Boxenbaum andS. Spector,Radio immunoassay of atropine in plasma, Exp. Ther.203, 435\u2013441 (1977).","journal-title":"Exp. Ther."},{"key":"BF02004716_CR7","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jps.2600640220","volume":"64","author":"W.F. Bayne","year":"1975","unstructured":"W.F. Bayne, F.T. Tao andN. Crisologo,Submicrogram assay for scopolamin in plasma and urine, J. Pharm. Sci.64, 288\u2013291 (1975).","journal-title":"J. Pharm. Sci."},{"key":"BF02004716_CR8","first-page":"515","volume-title":"The Pharmacological Basis of Therapeutics","author":"L.S. Goodman","year":"1977","unstructured":"L.S. Goodman andA. Gilman,The Pharmacological Basis of Therapeutics, 5th edn, p. 515. The MacMillan Company, New York 1977.","edition":"5th edn"},{"key":"BF02004716_CR9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/jps.2600560213","volume":"56","author":"G.C. Schmidt","year":"1976","unstructured":"G.C. Schmidt, T.E. Eling andJ.C. Drach,Synthesis of tropine labelled atropine I, micromethods for the synthesis of tropine and for its esterification with tropic acid, J. Pharm. Sci.56, 215\u2013221 (1976).","journal-title":"J. Pharm. Sci."},{"key":"BF02004716_CR10","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/ja01121a504","volume":"74","author":"F. Blicke","year":"1952","unstructured":"F. Blicke, H. Raffelson andB. Barna,The preparation of tropic acid, J. Amer. Clin. Soc.74, 253 (1952).","journal-title":"J. Amer. Clin. Soc."},{"key":"BF02004716_CR11","unstructured":"J. Van de Kamp andMeyer Sletzinger,Production of tropine, U.S. Patent Office, U.S. Pat. 2,366,760 (1945)."},{"key":"BF02004716_CR12","unstructured":"A. Stoll, E. Jucker andA. Lindemann,Process for the preparation of alkoxy-tetrahydrofuranes, U.S. Patent Office, U.S. Pat. 2,746,976 (1956)."},{"key":"BF02004716_CR13","first-page":"9","volume-title":"The Determination of Ionization Constants","author":"A. Albert","year":"1971","unstructured":"A. Albert andE.P. Serjeant,The Determination of Ionization Constants, p. 9, Chapman and Hall, London 1971."},{"key":"BF02004716_CR14","first-page":"281","volume-title":"The Determination of Ionization Constants","author":"A. Albert","year":"1971","unstructured":"A. Albert andE.P. Serjeant,The Determination of Ionization Constants, p. 281. Chapman and Hall, London 1971."},{"key":"BF02004716_CR15","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/jps.2600631103","volume":"63","author":"P.H. Hinderling","year":"1974","unstructured":"P.H. Hinderling, J. Br\u00e8s andE.R. Garrett,Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite, J. Pharm. Sci.,63, 1684\u20131690 (1974).","journal-title":"J. Pharm. Sci."},{"key":"BF02004716_CR16","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF01969571","volume":"7","author":"P.H. Hinderling","year":"1977","unstructured":"P.H. Hinderling,Comparative studies of the protein binding of digoxin and its metabolites, Agents and Actions7, 379\u2013382 (1977).","journal-title":"Agents and Actions"},{"key":"BF02004716_CR17","unstructured":"A. Roos andP.H., Hinderling,Protein binding and erythrocyte partitioning of the antirheumatic proquazone, J. Pharm. Sci. (in press)."},{"key":"BF02004716_CR18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/clinchem\/10.10.918","volume":"10","author":"L.T. Skeggs Jr","year":"1964","unstructured":"L.T. Skeggs Jr andH. Hochstrasser,Multiple automatic sequential analysis, Clin. Chem.,10, 918\u2013936 (1964).","journal-title":"Clin. Chem."},{"key":"BF02004716_CR19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0003-2697(66)90246-6","volume":"15","author":"C.B. Laurell","year":"1966","unstructured":"C.B. Laurell,Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies, Analyt. Biochem.15, 45\u201350 1966.","journal-title":"Analyt. Biochem."},{"key":"BF02004716_CR20","first-page":"582","volume-title":"Documenta Geigy","year":"1975","unstructured":"Documenta Geigy, 7th edn (EdsK. Diem andC. Lentner), p. 582. Ciba-Geigy Corporation, Ardsley, New York 1975.","edition":"7th edn"},{"key":"BF02004716_CR21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/jps.3030450707","volume":"45","author":"P. Zwirblis","year":"1956","unstructured":"P. Zwirblis, J. Socholitsky andA. Kondritzer,The kinetics of the hydrolysis of atropine. J. Am. Pharmaceut. Ass. Sci. Ed.45, 450\u2013454 1956.","journal-title":"J. Am. Pharmaceut. Ass. Sci. Ed."},{"key":"BF02004716_CR22","first-page":"18","volume-title":"The Determination of Ionization Constants","author":"A. Albert","year":"1971","unstructured":"A. Albert andE.P. Serjeant,The Determination of Ionization Constants, p. 18, Chapman and Hall, London 1971."},{"key":"BF02004716_CR23","first-page":"325","volume":"113","author":"L.S. Schanker","year":"1961","unstructured":"L.S. Schanker, P.A. Nafpliotis andJ.M. Johnson,Passage of organic bases into human red cells, J. Pharmac. Exp. Therap.113, 325\u2013331 1961.","journal-title":"J. Pharmac. Exp. Therap."},{"key":"BF02004716_CR24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00997082","volume":"270","author":"U. Abshagen","year":"1971","unstructured":"U. Abshagen, H. Kewitz andN. Rietbrock,Distribution of digoxin, digitoxin and ouabain between plasma and erythrocytes in various species,. Naunyn-Schmiedebergs Arch. Pharmak.270, 105\u2013116 (1971).","journal-title":"Naunyn-Schmiedebergs Arch. Pharmak."},{"key":"BF02004716_CR25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00561547","volume":"10","author":"W. Dieterle","year":"1976","unstructured":"W. Dieterle, J. Wagner andJ.W. Faigle,Binding of chlorthalidone (Hygroton \u00ae)to blood components in man, Eur. J. Clin. Pharmac.10, 37\u201342 (1976).","journal-title":"Eur. J. Clin. Pharmac."},{"key":"BF02004716_CR26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1172\/JCI101448","volume":"22","author":"B.D. Davis","year":"1943","unstructured":"B.D. Davis,The binding of sulfonamide drugs by plasma proteins. A factor in determining the distribution of drugs in the body, J. Clin. Invest.22, 753\u2013762 (1943).","journal-title":"J. Clin. Invest."},{"key":"BF02004716_CR27","first-page":"45","volume-title":"Pharmacokinetics","author":"M. Gibaldi","year":"1975","unstructured":"M. Gibaldi andD. Perrier,Pharmacokinetics,. p. 45. Marcel Decker, New York 1975."},{"key":"BF02004716_CR28","first-page":"146","volume-title":"The Mathematical Approach to Physiological Problems","author":"D.S. Riggs","year":"1963","unstructured":"D.S. Riggs,The Mathematical Approach to Physiological Problems, p. 146. Williams and Wilkins, Baltimore 1963."},{"key":"BF02004716_CR29","first-page":"289","volume":"162","author":"J.M. Kolthoff","year":"1925","unstructured":"J.M. Kolthoff,Die Dissoziationskonstante, das L\u00f6slichkeitsprodukt und die Titrierbarkeit von Alkaloiden, Biochem. Z.162, 289\u2013353 (1925).","journal-title":"Biochem. Z."},{"key":"BF02004716_CR30","first-page":"587","volume":"30","author":"F. M\u00fcller","year":"1924","unstructured":"F. M\u00fcller,Die Potentiometrische Bestimmung von Alkaloiden an der Wasserstoffelektrode, Z. f\u00fcr Elektrochemie30, 587\u2013600 (1924).","journal-title":"Z. f\u00fcr Elektrochemie"},{"key":"BF02004716_CR31","unstructured":"The Merck Index, 9th edn. Merck and Co. Rahway 1968"},{"key":"BF02004716_CR32","first-page":"136","volume":"4","author":"A. Alberti","year":"1952","unstructured":"A. Alberti,Ionization, pH and biological activity, Pharmac. Review4, 136\u2013167 (1952).","journal-title":"Pharmac. Review"},{"key":"BF02004716_CR33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jps.3030490515","volume":"49","author":"E. Kr\u00fcger-Thiermer","year":"1960","unstructured":"E. Kr\u00fcger-Thiermer,Dosage schedule and pharmacokinetics in chemotherapy, J. Am. Pharmaceut. Ass. Sci. Ed.49, 311\u2013313 (1960).","journal-title":"J. Am. Pharmaceut. Ass. Sci. Ed."},{"key":"BF02004716_CR34","first-page":"346","volume":"16","author":"P. Spring","year":"1966","unstructured":"P. Spring,Die Bindung einiger Sulfanilamide an die Bluteiweissk\u00f6rper des Menschen, Drug Res.16, 346\u2013354 (1966).","journal-title":"Drug Res."},{"key":"BF02004716_CR35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2362.1974.tb00372.x","volume":"4","author":"P. Kramer","year":"1974","unstructured":"P. Kramer, E. K\u00f6the.,J. Saul andF. Scheler,Uraemic and normal plasma protein binding of various cardiac\/glycosides under \u2018in vivo\u2019 conditions, Eur. J. Clin. Invest.4, 53\u201358 (1974).","journal-title":"Eur. J. Clin. Invest."},{"key":"BF02004716_CR36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0773.1956.tb01384.x","volume":"12","author":"M. T\u00f8nnesen","year":"1956","unstructured":"M. T\u00f8nnesen,On the absorption of atropine to plasma proteins, Acta pharmacol. et toxicol.12, 247\u2013250 (1956).","journal-title":"Acta pharmacol. et toxicol."},{"key":"BF02004716_CR37","first-page":"46","volume":"14","author":"J. Judis","year":"1979","unstructured":"J. Judis,Binding of amphetamine, atropine, epinephrine and histamine to human serum proteins, Can. J. Pharm. Sci.14, 46\u201350 (1979).","journal-title":"Can. J. Pharm. Sci."}],"container-title":["Agents and Actions"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02004716.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02004716\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02004716","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T21:43:28Z","timestamp":1586382208000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02004716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1981,11]]}},"alternative-id":["BF02004716"],"URL":"https:\/\/doi.org\/10.1007\/bf02004716","relation":{},"ISSN":["0065-4299","1420-908X"],"issn-type":[{"value":"0065-4299","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,11]]}}}